Increased the size of two of its major facilities with an expansion of its Corporate Headquarters in Cleveland, OH, and an entirely new, modern facility for its R&D Center of Excellence and International Operations in Israel.
Cleveland, OH, USA: Simbionix USA Corporation, the world's leading provider of medical education and simulation training products for medical professionals and the healthcare industry, is pleased to announce the company's continued global expansion.
Simbionix has increased the size of two of its major facilities with an expansion of its Corporate Headquarters in Cleveland, OH, and an entirely new, modern facility for its R&D Center of Excellence and International Operations in Israel.
Simbionix increased its investment at a time when many companies in our industry have decided to hold back on such activities, in order to further demonstrate our ongoing commitment to R&D, new product development and global customer support.
The creation of the Simbionix Medical Education Division (MED) was one of the driving forces behind the expansion of the company's headquarters in Cleveland, OH, as well as the need to support increasing market demand.
The R&D Center of Excellence and International Operations in Israel moved to new offices in the new, high tech Airport City Business Complex to support the company's strategic growth objectives and further enhance global reach.
"The demand for our products and services continues to grow as medical simulators and e-learning become a more common element in the training and education of surgeons and healthcare clinicians," commented Gary Zamler, CEO of Simbionix.
"Based on record sales over the last three years, increasing market demand for our innovative simulations and training solutions and services, as well as our internal company growth forecasts, we decided to invest in larger facilities to enable us to provide even faster response and better service to our clients worldwide.
Everyone at Simbionix is thrilled and excited.
These investments in our new facilities reinforce the company's ongoing commitment to provide exceptional products and services to the medical community."